Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients
Phase 1
Recruiting
- Conditions
- Celiac DiseaseHealthy VolunteersType 1 Diabetes
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Mozart Therapeutics Australia Pty Ltd
- Target Recruit Count
- 96
- Registration Number
- NCT06324604
- Locations
- 🇦🇺
Wesley Research Institute, Auchenflower, Queensland, Australia
🇦🇺Nucleus Network Brisbane, Herston, Queensland, Australia
🇦🇺The Royal Melbourne Hospital, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath